The Part 11 Controversy: A Root Cause Analysis and Science-Based Solutions

The confusion surrounding the application of 21 CFR Part 11 can be solved by focusing on the common rationale that both protects the public health and drives the fundamental basis of the industry's business: good science.

Related Content:

Quality SystemsInformation TechnologyPharmaceutical Technology-06-01-2005

FDA Inspectors Cited Critical Problems at Emergent Facility

Focusing on Accelerated Formulation Strategies

Understanding the Impact of Annex 1 on Isolator Operation